In Europe, a renewed interest in promoting and improving collaboration in clinical and translational research in lung cancer has emerged. Many investigators, representing collaborative study groups and institutions, are trying to find new ways to improve dissemination of knowledge and expertise in the field of rapidly evolving customized therapy. To accomplish this goal, discussions with European investigators during one of the thoracic oncology meetings in Dublin (BTOG) were initiated in early...